Skip to main content
Fig. 5 | BMC Neuroscience

Fig. 5

From: Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer’s disease

Fig. 5

Docking analysis of benperidol and anisoperidone with beta-secretase cleavage enzyme (2HM1) depicting the ligand and protein interaction at the active site. The secondary structure of the protein is shown as a solid grey ribbon. Multicolor dots and lines represent key residues. In each fig a represents Two dimensional (2D) interaction between ligand and macromolecule and the legend represents the interaction type between the amino acid of the macromolecule and the ligand atoms. The b shows the three-dimensional (3D) binding of drug with macromolecule

Back to article page